Predicting the response to immunotherapy from gene expression data in HER2-negative breast cancer
Our analysis shows that ARIADNE is predictive of the response to immunotherapy, but not to chemotherapy, in HER2- patients.
Authors
- Ornella Garrone (ORCID: https://orcid.org/0000-0001-7359-5410)
- Caterina A. M. La Porta (ORCID: https://orcid.org/0000-0002-3010-8966)
- Stefano Zapperi (ORCID: https://orcid.org/0000-0001-5692-5465)
- M. Merlano
Institutions
- University of Milan (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Institute of Condensed Matter Chemistry and Technologies for Energy (IT)
- Candiolo Cancer Institute (IT)
Publication Details
- Journal
- Communications Medicine
- Published
- 2025-10-03
- DOI
- https://doi.org/10.1038/s43856-025-01131-y
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Associazione Italiana per la Ricerca sul Cancro